STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice.

MLA

Meyer-Losic, Florence, et al. “STX140, but Not Paclitaxel, Inhibits Mammary Tumour Initiation and Progression in C3(1)/SV40 T/t-Antigen Transgenic Mice.” PloS One, vol. 8, no. 12, Dec. 2013, p. e80305. EBSCOhost, https://doi.org/10.1371/journal.pone.0080305.

APA

Meyer-Losic, F., Newman, S. P., Day, J. M., Reed, M. J., Kasprzyk, P. G., Purohit, A., & Foster, P. A. (2013). STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice. PloS One, 8(12), e80305. https://doi.org/10.1371/journal.pone.0080305

Chicago

Meyer-Losic, Florence, Simon P Newman, Joanna M Day, Michael J Reed, Philip G Kasprzyk, Atul Purohit, and Paul A Foster. 2013. “STX140, but Not Paclitaxel, Inhibits Mammary Tumour Initiation and Progression in C3(1)/SV40 T/t-Antigen Transgenic Mice.” PloS One 8 (12): e80305. doi:10.1371/journal.pone.0080305.